• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    AIX Completes Strategic Share Exchange with BGM to Drive Growth in AI Insurance and Healthcare

    12/27/24 9:00:00 AM ET
    $AIFU
    $BGM
    Specialty Insurers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIFU alert in real time by email

    GUANGZHOU, China, Dec. 27, 2024 (GLOBE NEWSWIRE) -- AIX Inc. (the "Company" or AIX) (NASDAQ:AIFU), a leading independent technology-driven financial services provider in China, today announced the successful completion of its strategic share exchange transaction with BGM Group Ltd. (BGM) (NASDAQ:BGM), marking a significant milestone in its long-term transformation within the AI-driven insurance and healthcare space, and establishing a strong foundation for its future diversified growth.

    As part of the transaction, AIX transferred its intelligent insurance platform, including RONS Intelligent Technology (Beijing) Co., Ltd. ("RONS Technology"), to BGM in exchange for 69,995,661 Class A ordinary shares of BGM. Upon completion of this transaction, BGM will take full control of the intelligent platform and leverage its extensive resources in the global healthcare sector to accelerate the platform's development and innovation.

    Key Highlights of the Transaction:

    Growth Potential: The AI insurance platform Du Xiaobao has significant market potential. Powered by big data, the platform offers personalized insurance solutions and is poised to drive strong growth for BGM in the coming years. AIX, through its significant equity stake in BGM, will continue to benefit from the platform's development and market expansion.

    Business Synergy: The partnership with BGM, a global leader in the pharmaceutical industry, enhances AIX's presence not only in AI insurance but also in the healthcare sector. This synergy creates unique opportunities to integrate AI, insurance, and healthcare solutions, positioning both companies for long-term leadership across multiple industries.

    AI and Healthcare Strategy: With growing demands for healthcare services globally, particularly due to an aging population, AIX is leveraging AI technology to offer tailored insurance and healthcare solutions. Through its partnership with BGM, AIX is solidifying its position at the intersection of AI, insurance, and healthcare sectors poised for significant growth. This integrated strategy is expected to be a driving force for future innovation and value creation.

    Valuation Re-Discovery and Strategic Breakthrough: As AIX expands into the healthcare sector with its equity stake in BGM, the Company believes that it will benefit from any revaluation driven by the platform's growth and the increasing market demand for AI-driven insurance and healthcare solutions.

    Mr. Yinan Hu, Vice Chairman and CEO of AIX, commented: "The completion of this transaction marks a significant step forward in our strategy to lead the transformation of the insurance and healthcare industries through AI. Our partnership with BGM enables us to tap into new growth opportunities and further strengthen our position in both the AI and healthcare sectors. We look forward to continuing to innovate and deliver substantial value to our stakeholders."

    Mr. Xin Chen, CEO of BGM, stated: "This transaction accelerates our ability to leverage AI in the insurance and healthcare industries. With the growing demand for innovative healthcare solutions driven by AI and big data, we are well-positioned to capture significant market opportunities. We are excited about the future and look forward to driving growth and innovation alongside AIX."

    As the global healthcare landscape evolves, the strategic partnership between AIX and BGM positions both companies to lead the way in AI-driven insurance and healthcare solutions. By combining their respective strengths, the two companies are set to unlock new growth avenues, create lasting value for their shareholders, and drive the digital transformation of the industries they serve.

    About AIX Inc.

    AIX, established in 1998, is a leading intelligent technology-driven independent financial services provider in China. It provides 400 million middle-class families with insurance protection, wealth management, and value-added services and provides independent financial advisors and various insurance/financial sales organizations with technical support and comprehensive solutions. Through AI-driven insights and cutting-edge digital tools, AIX has successfully established itself as a leader in intelligent transformation within the financial services industry.

    Forward-looking Statements

    This press release contains statements of a forward-looking nature. These statements, including the statements relating to the Company's future financial and operating results, are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by terminology such as "will", "expects", "believes", "anticipates", "intends", "estimates" and similar statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about AIX Inc. and the industry. Potential risks and uncertainties include, but are not limited to, those relating to its ability to attract and retain productive agents, especially entrepreneurial agents, its ability to maintain existing and develop new business relationships with insurance companies, its ability to execute its growth strategy, its ability to adapt to the evolving regulatory environment in the Chinese insurance industry, its ability to compete effectively against its competitors, quarterly variations in its operating results caused by factors beyond its control including macroeconomic conditions in China. Except as otherwise indicated, all information provided in this press release speaks as of the date hereof, and AIX Inc. undertakes no obligation to update any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although AIX Inc. believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results. Further information regarding risks and uncertainties faced by AIX Inc. is included in AIX Inc.'s filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F.



    For more information, please contact:
    AIX Inc. 
    Investor Relations
    Tel: +86 (20) 8388-3191
    Email: [email protected]

    Primary Logo

    Get the next $AIFU alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AIFU
    $BGM

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $AIFU
    $BGM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem

      CHENGDU, China, May 2, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) (the "Company" or "BGM") , a leading AI technology company, today announced it has entered into a definitive agreement (the "Agreement") to acquire HM Management Company Limited ("HM Management"), a prominent AI agent production platform, in an all-stock transaction valued at approximately RMB300 million (US$41.7 million). Under the Agreement, BGM will issue 16,663,427 Class A ordinary shares at $2.50 per share to acquire 100% ownership of HM Management and its two wholly-owned subsidiaries: Beijing Shuda Technology Company Limited. ("Shuda Technology") and New Media Star Technology (Shenzhen) Co., Ltd ( "New Media Star

      5/2/25 8:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BGM Completes Acquisition of YX to Advance AI-Powered Intelligent Platform

      CHENGDU, China, April 28, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) (the "Company" or BGM)  today announced the completion of its acquisition of YX Management Company Ltd. ("YX"), an leading intelligent mobility technology platform, on April 25, 2025. As previously disclosed, BGM acquired 100% of YX by issuing 47.5 million Class A ordinary shares to YX's existing shareholders, representing a valuation of US$95.0 million. Upon completion of the acquisition, YX's shareholders collectively own approximately 32.6% of BGM's equity interests and approximately 2.2% of the total voting power. This acquisition represents a significant step in BGM's AI-driven transformation, enhancing its capa

      4/28/25 8:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • AIFU Files Annual Report on Form 20-F on April 25, 2025

      GUANGZHOU, China, April 25, 2025 (GLOBE NEWSWIRE) -- AIFU Inc. (NASDAQ:AIFU) (the "Company" or "AIFU"), a leading AI-driven independent financial services platform in China, today announced that it has filed its 2024 annual report on Form 20-F (the "2024 20-F"), which contains its audited financial statements for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (the "SEC") on April 25, 2025. The 2024 20-F can be accessed on the SEC's website at http://www.sec.gov as well as on the Investor Relations page of the Company's website at http://ir.aifugroup.com/financial-information/sec-filings. Hard copies of the annual report are available, free of char

      4/25/25 5:00:47 PM ET
      $AIFU
      Specialty Insurers
      Finance

    $AIFU
    $BGM
    SEC Filings

    See more
    • SEC Form 6-K filed by AIFU Inc.

      6-K - AIFU Inc. (0001413855) (Filer)

      5/16/25 7:00:30 AM ET
      $AIFU
      Specialty Insurers
      Finance
    • Amendment: SEC Form 20-F/A filed by BGM Group Ltd.

      20-F/A - BGM Group Ltd. (0001779578) (Filer)

      5/8/25 8:04:36 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by BGM Group Ltd.

      6-K - BGM Group Ltd. (0001779578) (Filer)

      5/6/25 9:06:17 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $AIFU
    $BGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by BGM Group Ltd.

      SC 13D - BGM Group Ltd. (0001779578) (Subject)

      12/3/24 6:03:06 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13D/A filed by BGM Group Ltd.

      SC 13D/A - BGM Group Ltd. (0001779578) (Subject)

      11/29/24 9:00:27 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D filed by Qilian International Holding Group Ltd.

      SC 13D - Qilian International Holding Group Ltd (0001779578) (Subject)

      10/16/24 4:19:46 PM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $AIFU
    $BGM
    Leadership Updates

    Live Leadership Updates

    See more
    • BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution

      CHENGDU, China, Feb. 28, 2025 /PRNewswire/ -- BGM Group Ltd (NASDAQ:BGM) (the "Company" or "BGM") today announced changes to its board of directors, marking the Company's entry into a new phase of technological transformation and sustainable growth. Mr. Zhanchang Xin has tendered his resignation and will step down from his role as Chairman of the Company, effective March 1, 2025. He will be succeeded by Mr. Chen Xin, the current Chief Executive Officer of the Company, who will assume the position of Chairman. As the founder of the Company, Mr. Zhanchang Xin has, over the past six decades, has played a pivotal role in leading the Company through numerous challenges and milestones, including

      2/28/25 8:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BGM Group Establishes "Duxiaobao Management Committee" to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry

      CHENGDU, China, Feb. 19, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the management and decision-making of the "Duxiaobao" ecosystem. This move signifies BGM Group's strategic entry into the field of artificial intelligence, aiming to accelerate the transformation of the insurance industry into the smart era through AI technology. The Duxiaobao Management Committee consists of industry leaders such as Xin Chen, Li Yuqing, Ge Peng, Zhao Qi, Ren Yong, Li Jun, Zhou Xin, and Wang Hui. The committee has appointed Li Yuqing as the CEO of Duxiaobao, with Li Jun, Ren Yong, Zhou Xin, and Tan

      2/19/25 7:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • AIX Announces Changes to the Board of Directors and Management Team

      GUANGZHOU, China, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The board of directors (the "Board") of AIX Inc. (NASDAQ:AIFU) (the "Company" or "AIX"), a leading independent technology-driven financial services provider in China, today announced that Mr. Ning Li has been appointed as Co-Chief Executive Officer and Executive Director of the Board, effective immediately. Mr. Ning Li served as Executive Director from 2017 to 2022 and Chief Financial Officer from 2010 to 2022 at CNFinance Holdings Ltd. Prior to that, he served as a Financial Director at AIX Inc. from 2006 to 2009. He served as Financial Controller at China Textile Import & Export Group and a Financial Director in one of its foreign repr

      11/22/24 6:37:06 AM ET
      $AIFU
      Specialty Insurers
      Finance

    $AIFU
    $BGM
    Financials

    Live finance-specific insights

    See more
    • BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

      CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordinary shares at a price of $2 per share, for a total transaction valuation of RMB550 million. The transaction is expected to be completed in the second quarter of 2025. Wonder Dragon possesses over 3,000 metric tons of premium Qingzhuan dark tea inventory, comprising 1,670 metric tons of raw materials and 1,350 metric tons of finished products. These premium tea products, known f

      4/21/25 8:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform

      CHENGDU, China, March 19, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM) (NASDAQ:BGM) today announced that it has signed a definitive agreement with the existing shareholders of YX Management Company Ltd. ("YX"), a smart mobility technology company. Under the agreement, BGM will acquire 100% of the equity interests of YX by issuing 47.5 million class A ordinary shares to its existing shareholders, valuing YX at US$95.0 million. This acquisition is based on the exceptional expertise and experience of the YX team in scalable operations, digital infrastructure development, and technology commercialization. The integration of this team will accelerate the AI-driven strategic upgrade

      3/19/25 8:30:00 AM ET
      $BGM
      Biotechnology: Pharmaceutical Preparations
      Health Care